Moore KT, Langas M. Use of Rivaroxaban and Apixaban, Two Non-Vitamin K Antagonist Oral Anticoagulants (NOACs), in Renally Impaired Patients - the limits of our knowledge. J Cardiol Cardiovasc Med [Internet]. 2018 Oct. 11 [cited 2025 May 23];3(3):049-51. Available from: https://www.cardiologymedjournal.com/jccm/article/view/jccm-aid1026